Evidence map›Paper›PMID 32215557›Full record

ArticleJapanese journal of clinical oncology2020

JPOS/JASCC clinical guidelines for delirium in adult cancer patients: a summary of recommendation statements.

Yoshinobu Matsuda, Hitoshi Tanimukai, Shinichiro Inoue, Shuji Inada, Koji Sugano, Hideaki Hasuo, Masafumi Yoshimura, Saho Wada, Chikako Dotani, Hiroyoshi Adachi and 11 more

Open access · hybridAbstract read
In one paragraph

Article in Japanese journal of clinical oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 2 pooled it
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 syntheses or guidelines pooled it, 17 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 16 institutions in 1 country.

Yoshinobu MatsudaDepartment of Psychosomatic Internal Medicine, National Hospital Organization Kinki-Chuo Chest Medical Center, Sakai, Japan.
Hitoshi TanimukaiFaculty of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Shinichiro InoueDepartment of Neuropsychiatry, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Science, Okayama, Japan.
Shuji InadaDepartment of Psychosomatic Medicine, The University of Tokyo Hospital, Tokyo, Japan.
Koji SuganoDivision of Respiratory Medicine, Juntendo Tokyo Koto Geriatric Medical Center, Tokyo, Japan.
Hideaki HasuoDepartment of Psychosomatic Medicine, Kansai Medical University, Hirakata, Japan.
Masafumi YoshimuraDepartment of Neuropsychiatry, Kansai Medical University, Moriguchi, Japan.
Saho WadaDepartment of Psycho-Oncology, National Cancer Center Hospital, Tokyo, Japan.
Chikako DotaniDepartment of Pediatrics, The University of Tokyo Hospital, Tokyo, Japan.
Hiroyoshi AdachiSleep Medicine Center, Osaka University Hospital, Suita, Japan.
Yoshiaki OkamotoDepartment of Pharmacy, Ashiya Municipal Hospital, Ashiya, Japan.
Mari TakeuchiDepartment of Palliative Care, Keio University School of Medicine, Tokyo, Japan.
Daisuke FujisawaDivision of Patient Safety, Keio University School of Medicine, Tokyo, Japan.
Jun KakoDivision of Nursing Science, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Chiyuki SasakiNursing Department, National Cancer Center Hospital, Tokyo, Japan.
Yasuhiro KishiDepartment of Psychiatry, Nippon Medical School Musashikosugi Hospital, Kawasaki 211-8533, Japan.
Nobuya AkizukiDepartment of Psycho-Oncology/Psychiatry, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo 113-8677, Japan.
Masatoshi InagakiDepartment of Psychiatry, Faculty of Medicine, Shimane University, Izumo 693-8501, Japan.
Yosuke UchitomiInnovation Center for Supportive, Palliative and Psychosocial Care, National Cancer Center Hospital, Tokyo 104-0045, Japan.
Eisuke MatsushimaSection of Liaison Psychiatry and Palliative Medicine, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo 113-8519, Japan.
Toru OkuyamaDivision of Psycho-oncology and Palliative Care, Nagoya City University Hospital, Mizuho-cho, Mizuho-ku, Nagoya, Aichi 467-8601, Japan.
Kansai Medical University · JPKeio University · JPUniversity of Tokyo Hospital · JPAshiya University · JPHiroshima University · JPKyoto University · JPNagoya City University Hospital · JPNational Kinki Chuo Hospital for Chest Disease · JPNippon Medical School · JPOkayama University · JPOsaka University Hospital · JPShimane University · JPTokyo Medical and Dental University · JPTokyo Metropolitan Geriatric Hospital · JPTokyo Metropolitan Komagome Hospital · JPTokyo National Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe Japanese Psycho-Oncology Society and Japanese Association of Supportive Care in Cancer recently launched the clinical practice guidelines for delirium in adult cancer patients. The aim of the guidelines was to provide evidence-based recommendations for the clinical assessment and management of delirium in cancer patients. This article reports the process of developing the guideline and summarizes the recommendations made.

methodsThe guidelines were developed in accordance with the Medical Information Network Distribution Service creation procedures. The guideline development group, consisting of multidisciplinary members, formulated nine clinical questions. A systematic literature search was conducted to identify relevant articles published prior to through 31 May 2016. Each article was reviewed by two independent reviewers. The level of evidence and the strength of the recommendations were graded using the grading system developed by the Medical Information Network Distribution Service, following the concept of The Grading of Recommendations Assessment, Development and Evaluation system. The modified Delphi method was used to validate the recommendation statements.

resultsThis article provides a summary of the recommendations with rationales for each, as well as a short summary.

conclusionsThese guidelines will support the clinical assessment and management of delirium in cancer patients. However, additional clinical studies are warranted to further improve the management of delirium.

Indexed as

Health Planning GuidelinesPractice Guidelines as TopicSocieties, MedicalAdultAntipsychotic AgentsDeliriumHumansJapanNeoplasmsSocial SupportTerminally IllAntipsychotic Agentscancerdeliriumguidelinepalliative carepsycho-oncology

Identifiers

PMID32215557
PMCPMC7202141
OpenAlexW3013969298

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.